Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  PI3K/mTOR dual kinase inhibitor XL765
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Phase: Phase II, Phase I
Type: Treatment
Age: not specified
Trial IDs: TED12414, NCI-2012-02198, 2011-006140-78, U1111-1124-1403, NCT01587040
Start Over